Header Logo
Newsletter Podcast
Log In
← Back to all posts

PRP Wins Big, Raise Your Rates, Master Your Marketing

Apr 22, 2025
Connect

Highlights

  • Today’s Research Article: PRP delivers twice the healing at six months compared to steroids — and helps patients avoid surgery.

  • Questions from the Field: When your results are better, your price should be too — charge for the quality and outcomes you deliver.

  • Let’s Get Down to Business: If patients can’t find you online, they’ll never book — make digital marketing your best closer.

  • Come Join Us: Level up your skills and network with the best at these must-attend orthobiologics events!

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Autologous Platelet‐rich Plasma versus Corticosteroid in the Management of Elbow Epicondylitis: A Randomized Study

Ankit Varshney, Rajesh Maheshwari, Anil Juyal, Atul Agrawal, Prabhnoor Hayer

Read the full article here.

Summary:

In this randomized study by Varshney et al., 112 patients with elbow epicondylitis were treated with either a corticosteroid injection or autologous platelet-rich plasma (PRP) injection and followed for six months. Both groups showed comparable pain and function improvement at 1 and 2 months, but significant differences emerged later: at 6 months, PRP patients had a 91% improvement in pain scores compared to 42.2% in the steroid group, and a 54.4% improvement in function scores versus only 1.25% with steroids. Importantly, no complications such as infections were reported, although mild post-injection pain was noted.

The findings suggest that while corticosteroids provide short-term relief, PRP leads to superior and longer-lasting improvements by promoting true healing at the tendon level. PRP offers a regenerative treatment approach, whereas steroids mainly suppress inflammation temporarily and may cause structural tendon changes over time. The study concludes that PRP should be considered as a primary nonsurgical option for managing elbow epicondylitis, especially for patients who seek durable recovery without the risks of tendon degeneration.

Talking Points for Doctors to Patients: Why Choose PRP

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP’s edge on back pain, smarter marketing, and a live demo invite
Highlights Today’s Research Article: PRP outlasts steroids—stronger, safer, longer relief for back pain. Questions from the Field: From blood draw to injection: PRP takes just 20–25 minutes. Let’s Get Down to Business: Marketing isn’t sales—it’s how patients discover you. Come Join Us: See PRP in action—live demo & Q&A with Dr. Ariana DeMers.   If this newsletter was forwarded to you and you...
Stronger Shoulders, Smarter PRP, Better Marketing
Highlights Today’s Research Article: PRP beats PT in restoring shoulder function—lasting results without surgery. Questions from the Field: Not all PRP systems are equal—know your spin, know your outcomes. Let’s Get Down to Business: Doctors shouldn’t market alone—team up and thrive in today’s digital age. Come Join Us: Turn orthobiologic knowledge into profit at BOB Live—your Monday-r...
Grade IV OA? PRP Delivers – Plus, What to Do When Patients Don’t Respond
Highlights Today’s Research Article: Grade IV knee arthritis patients move better, hurt less, and skip the scalpel. Questions from the Field: When PRP results fall short, smart testing and re-dosing can turn non-responders into success stories. Let’s Get Down to Business: Connect, refer, and watch your practice grow. Come Join Us: BOB Live turns knowledge into profit   Turn what you...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.